Labad, Jesseca D.

HRN: 13-18-82  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/26/2025
CO-AMOXICLAV 625MG (TAB)
08/26/2025
09/01/2025
ORAL
500mg
BID
Sp PLTCS
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines